Rapid Dose Therapeutics Corp. (CSE:DOSE)
0.190
0.00 (0.00%)
Feb 20, 2025, 1:34 PM EST
Rapid Dose Therapeutics Balance Sheet
Financials in millions CAD. Fiscal year is March - February.
Millions CAD. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 30, 2024 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | Feb '20 Feb 29, 2020 | 2019 - 2018 |
Cash & Equivalents | 0.04 | 0.16 | 0.03 | 0.03 | 0.07 | 0 | Upgrade
|
Cash & Short-Term Investments | 0.04 | 0.16 | 0.03 | 0.03 | 0.07 | 0 | Upgrade
|
Cash Growth | -75.87% | 483.82% | -19.90% | -50.98% | 1925.43% | -99.90% | Upgrade
|
Accounts Receivable | 0.11 | 0.03 | 0.06 | 0.07 | 0.08 | 0.04 | Upgrade
|
Other Receivables | 0.14 | 0.19 | 0.09 | 0.11 | 0.17 | 0.07 | Upgrade
|
Receivables | 0.25 | 0.22 | 0.15 | 0.18 | 0.26 | 0.11 | Upgrade
|
Inventory | 0.28 | 0.17 | 0.16 | 0.28 | 0.37 | 0.21 | Upgrade
|
Prepaid Expenses | 0.04 | 0.1 | 0.06 | 0.09 | 0.1 | 0.09 | Upgrade
|
Other Current Assets | 0.03 | 0.03 | 0.03 | 0.03 | - | - | Upgrade
|
Total Current Assets | 0.64 | 0.68 | 0.42 | 0.61 | 0.8 | 0.41 | Upgrade
|
Property, Plant & Equipment | 1.03 | 1.21 | 1.83 | 2.45 | 3.03 | 3.88 | Upgrade
|
Total Assets | 1.67 | 1.89 | 2.25 | 3.07 | 3.83 | 4.29 | Upgrade
|
Accounts Payable | 1.53 | 1.12 | 2.78 | 1.36 | 1.83 | 1.55 | Upgrade
|
Accrued Expenses | 1.64 | 1.47 | - | - | - | - | Upgrade
|
Short-Term Debt | - | 0.21 | 1.57 | 0.76 | 1.23 | 0.13 | Upgrade
|
Current Portion of Long-Term Debt | - | 0.09 | 0.19 | - | - | - | Upgrade
|
Current Portion of Leases | - | 0.03 | 0.34 | 0.31 | 0.29 | 0.26 | Upgrade
|
Current Unearned Revenue | - | - | 0.01 | 0.02 | 0.9 | 1.53 | Upgrade
|
Total Current Liabilities | 3.16 | 2.92 | 4.89 | 2.45 | 4.25 | 3.48 | Upgrade
|
Long-Term Debt | 2.61 | 2.12 | - | - | - | - | Upgrade
|
Long-Term Leases | - | - | 0.03 | 0.36 | 0.67 | 0.96 | Upgrade
|
Total Liabilities | 5.77 | 5.04 | 4.92 | 2.82 | 4.92 | 4.44 | Upgrade
|
Common Stock | 28.07 | 26.61 | 25.13 | 25 | 18.6 | 18.09 | Upgrade
|
Additional Paid-In Capital | 6.28 | 5.24 | 4.85 | 4.15 | 2.64 | - | Upgrade
|
Retained Earnings | -42.98 | -39.26 | -34.97 | -31.16 | -22.67 | -20.86 | Upgrade
|
Comprehensive Income & Other | 4.52 | 4.24 | 2.32 | 2.26 | 0.34 | 2.62 | Upgrade
|
Shareholders' Equity | -4.1 | -3.16 | -2.67 | 0.25 | -1.09 | -0.15 | Upgrade
|
Total Liabilities & Equity | 1.67 | 1.89 | 2.25 | 3.07 | 3.83 | 4.29 | Upgrade
|
Total Debt | 2.61 | 2.45 | 2.12 | 1.43 | 2.19 | 1.35 | Upgrade
|
Net Cash (Debt) | -2.57 | -2.29 | -2.1 | -1.4 | -2.12 | -1.35 | Upgrade
|
Net Cash Per Share | -0.02 | -0.02 | -0.02 | -0.01 | -0.03 | -0.02 | Upgrade
|
Filing Date Shares Outstanding | 128.44 | 122.3 | 103.57 | 103.07 | 80.67 | 77.07 | Upgrade
|
Total Common Shares Outstanding | 128.44 | 117.81 | 103.57 | 103.07 | 80.67 | 77.07 | Upgrade
|
Working Capital | -2.52 | -2.24 | -4.47 | -1.84 | -3.45 | -3.06 | Upgrade
|
Book Value Per Share | -0.03 | -0.03 | -0.03 | 0.00 | -0.01 | -0.00 | Upgrade
|
Tangible Book Value | -4.1 | -3.16 | -2.67 | 0.25 | -1.09 | -0.15 | Upgrade
|
Tangible Book Value Per Share | -0.03 | -0.03 | -0.03 | 0.00 | -0.01 | -0.00 | Upgrade
|
Machinery | 2.4 | 2.39 | 2.39 | 2.39 | 2.21 | 2.37 | Upgrade
|
Leasehold Improvements | - | - | - | - | - | 0.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.